Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy (Journal of Neuroinflammation, (2023), 20, 1, (214), 10.1186/s12974-023-02895-7)

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy (Journal of Neuroinflammation, (2023), 20, 1, (214), 10.1186/s12974-023-02895-7)'. Together they form a unique fingerprint.

Medicine & Life Sciences